Which EDC Platforms Actually Use AI? 7 Systems Compared for Clinical Trials

AI in EDC systems refers to the use of technologies such as machine learning, natural-language processing, generative AI, and agentic AI to support clinical data workflows beyond predefined rules. Depending on the platform, AI can help build studies from protocols, extract source data, assist with medical coding, identify data discrepancies, generate queries, and let teams interact with clinical data using natural language.

The EDC market is projected to reach USD 3.64 billion by 2031, growing at an 11.86% CAGR, while AI is becoming a more visible part of how these systems support clinical data workflows.

But AI in EDC does not mean the same thing across platforms. One may use AI to review clinical data and suggest queries, another to generate eCRFs and edit checks from a protocol, while others focus on medical coding, source-data extraction, or natural-language reporting.

This makes what the AI actually does more useful to evaluate than whether a vendor simply describes its EDC as “AI-powered.”

In this comparison, we look at Castor EDC, Clinion EDC, CRScube cubeCDMS, Marvin EDC, Medidata Rave EDC, Medrio CDMS/EDC, and Zelta EDC to see where AI fits into their clinical data workflows and how human oversight is maintained.

EDC systems have automated tasks such as edit checks, alerts, data validation, and system integrations for years. These capabilities can reduce manual work, but they are not necessarily AI. For this comparison, we count a capability as AI when it uses technologies such as machine learning, natural-language processing, generative AI, or agentic AI to interpret, generate, extract, classify, predict, or reason over clinical trial information.

The distinction matters because automation and AI are not interchangeable. A highly automated EDC may have limited AI, while another platform may use AI for one specific but important clinical data-management task.

We focused on platforms where current vendor information identifies a specific AI capability connected to EDC or clinical data management, rather than relying only on broad claims such as “AI-powered.”

We looked at five things:

• AI use case: What task does the AI actually perform?
• Workflow: Does it support study build, data capture, coding, review, or reporting?
• EDC connection: Is the AI native to the EDC or part of an adjacent product?
• Human oversight: Can users review, approve, reject, or modify AI outputs?
• Availability: Is the capability documented as available today rather than only part of a future roadmap?

Note: The platforms are listed in alphabetical order and are not ranked by AI capability, market position, or overall EDC performance. 

The comparison table shows where AI fits across the seven platforms. The sections below look a little deeper at the specific AI capabilities each vendor documents, how they are being applied in clinical data workflows, and where human review remains part of the process.

Castor EDC

Castor uses AI mainly through Castor Catalyst, with the strongest focus on reducing manual source-data entry into the EDC.

• Catalyst can interpret source documents and EHR-derived data, then propose how that information should populate structured eCRF fields. It also shows source evidence and confidence information to support review.
• The workflow remains human-controlled: extracted values are reviewed before they become part of the trial record, so the AI assists data capture rather than replacing verification.
• Castor also uses AI to help structure incoming clinical information consistently, which can reduce the manual reconciliation needed when data originates from different source formats.

Key takeaway: Castor’s AI strength is source-to-EDC automation, especially for studies where manual transcription and source-data variability create significant workload.

Clinion EDC

Clinion applies AI across the EDC workflow, with its strongest differentiation in Agentic AI for clinical data review and its embedded Agentic Assistant.

• Its multi-agent data-review workflow interprets the protocol, CRF metadata, and existing edit checks to suggest review checks, identify contextual discrepancies, and prepare query drafts for data-manager review.
• Agentic Assistant brings protocol intelligence, operational metrics, and live clinical data querying into one conversational interface directly inside the EDC. Users can ask questions in natural language without SQL, with responses linked to the underlying study data.
• Clinion's broader EDC AI capabilities also include AI-assisted CDASH mapping, medical coding, audit-trail review, and report generation, extending AI beyond a single workflow.

Key takeaway: Clinion's AI is focused on bringing agentic intelligence directly into clinical data management, particularly data review, querying, and decision support while keeping data managers in control.

CRScube cubeCDMS

CRScube is applying AI primarily to study setup and medical coding, with recent development focused on reducing the manual work involved in configuring an EDC.

• Its AI Builder is designed to shorten EDC setup from weeks to days by using AI during study configuration. CRScube introduced the capability publicly in 2026 as part of its expanding AI functionality.
• cubeCDMS also includes AI-powered medical coding as part of its data-quality workflow, alongside its existing query-management and risk-based monitoring capabilities.
• The emphasis remains on assisting data managers rather than removing them from study design and coding decisions.

Key takeaway: CRScube's AI is concentrated around reducing EDC setup effort and supporting medical coding, rather than broad AI-driven data review.

Marvin EDC

Marvin uses AI mainly at the study-design and setup stage through Marvin Study Designer.

• From an uploaded protocol or study description, the AI can generate visits, eCRFs, fields, controlled terminology, validation rules, and edit checks as an initial study definition.
• It can also generate synthetic patient data and test users to support validation and UAT before study go-live.
• Marvin follows a human-in-the-loop approach: clinical experts review, refine, and approve generated study components before they are published into the EDC.

Key takeaway: Marvin's strongest AI use case is protocol-to-EDC study build, helping teams move faster from study design to a review-ready database.

Medidata Rave EDC

Medidata has one of the broader AI footprints in this comparison, although some capabilities sit across the wider Medidata clinical-data ecosystem rather than only inside Rave EDC.

• Medidata AI Study Build uses the protocol and generative AI to help configure Rave EDC and eCOA, reducing the manual work involved in translating protocol requirements into a study build.
• Coder+ applies predictive AI to medical coding and is trained on more than 90 million historical coding decisions, returning confidence-based coding predictions directly into Rave.
• Medidata also extends AI into broader clinical data-review and oversight workflows through applications such as Clinical Data Studio.

Key takeaway: Medidata stands out for the breadth and maturity of its AI ecosystem, spanning study build, coding, and clinical data management rather than one isolated use case.

Medrio CDMS/EDC

Medrio takes a more focused approach to AI, using it primarily to make clinical trial data easier for users to explore and report on.

• Its AI-enabled reporting capability is available within Medrio CDMS/EDC and uses natural-language interaction to help users explore clinical data without relying entirely on predefined reports.
• The use case is centered on making data access and reporting more accessible rather than using AI to automatically build studies or conduct clinical data review.
• Users remain responsible for determining the questions being asked and interpreting the resulting information.

Key takeaway: Medrio's AI strength is natural-language reporting and data exploration, giving study teams a simpler way to interact with clinical trial data.

Zelta EDC

Zelta has a relatively mature AI strategy built around supervised machine learning, with established applications in medical coding and study design.

• Medical Coding with AI provides predictive coding suggestions directly within the Zelta platform, helping reduce manual searches while keeping coders responsible for final decisions.
• Zelta also uses supervised machine learning to support CDASH annotation and accelerate the process of designing and standardizing CRFs.
• Its wider clinical data platform now includes Study Design Assistant AI and AI-assisted edit checks, expanding AI into study setup and data-quality workflows.

Key takeaway: Zelta's AI approach is targeted and ML-driven, with its clearest strengths in medical coding, study standardization, and study design.

The more meaningful shift is not that EDC platforms now “have AI.” It is that AI is starting to take on work that traditionally required significant manual interpretation, review, and configuration.

From Protocol to Study Build

AI can interpret protocol content and turn it into draft eCRFs, visit schedules, validation rules, edit checks, and other study-build components. This can reduce the time spent translating protocol requirements into an operational EDC setup.

From Verbatim Terms to Medical Codes

AI-assisted coding can interpret reported terms and suggest MedDRA or WHODrug codes with confidence scores, helping coders work through large volumes of terms more efficiently while retaining final approval.

From Source Data to Structured EDC Data

Instead of relying entirely on manual transcription, AI can extract information from source documents and EHR data, identify the relevant values, and map them into structured eCRF fields for review.

From Listings to Contextual Data Review

This is one of the more significant applications of AI in EDC. Rather than checking only predefined rules, AI can evaluate data in the context of the protocol, visits, related fields, and study logic to surface discrepancies that may require attention.

From Manual Queries to AI-Assisted Query Management

Once a potential issue is identified, AI can help generate context-specific query suggestions or draft query text, reducing repetitive work while keeping the data manager responsible for what is ultimately raised with the site.

From Static Reports to Conversational Data Access

Natural-language interfaces are making it possible for users to ask questions about study data, operational metrics, or protocol requirements without relying only on predefined dashboards, SQL, or manually created reports.

From Periodic Checks to More Continuous Oversight

AI can also help monitor incoming data for unusual patterns, inconsistencies, and emerging quality signals, allowing teams to focus attention earlier on areas that may need investigation.

The direction is clear: AI is moving EDC from rule-based data capture toward more context-aware support across study build, data review, coding, reporting, and oversight. The most valuable implementations are not those that automate the most tasks, but those that reduce manual effort without removing traceability, review, and human control.

AI should not be evaluated as a standalone feature. The more important question is whether it improves a real clinical data workflow while preserving validation, traceability, and human oversight.

When comparing AI-enabled EDC platforms, consider:

• What task does the AI actually perform? Look for a defined use case such as study build, coding, data review, source-data extraction, or reporting.
• Is the AI native to the EDC? Clarify whether the capability works directly inside the EDC workflow or depends on a separate product, integration, or service.
• How much human review is required? Users should be able to review, approve, reject, or modify AI-generated outputs before they affect study data or site queries.
• Can the output be traced? Teams should be able to understand what information the AI used and how its recommendations or generated outputs are reviewed and recorded.
• How is the AI validated and controlled? Ask how the vendor manages model updates, system validation, change control, and use in regulated workflows.
• How does it perform on your study? A meaningful evaluation should use representative protocols, CRFs, source data, coding terms, or review scenarios rather than a generic demonstration.
• What happens when the AI is uncertain? Confidence scoring, escalation, and clear handoff to human reviewers are important for higher-risk clinical data decisions.

The strongest AI capability is not necessarily the one that automates the most. It is the one that can reduce meaningful manual work while keeping clinical teams in control of the data, decisions, and audit trail.

The seven platforms above are not the only EDC vendors exploring AI. Several other established systems are adding AI capabilities, but the current evidence is either narrower, still emerging, or less clearly tied to core EDC workflows.

• Veeva Vault EDC: Veeva is expanding AI across its clinical platform, including planned Clinical Data AI agents. However, some of its more advanced clinical-data AI capabilities are still part of the rollout rather than long-established EDC functionality.
• Oracle Clinical One: Oracle describes Clinical One as AI-enabled and has introduced AI-supported connectivity and automation, but public detail on exactly how AI operates within core EDC data-management workflows remains limited.
• Viedoc EDC: Viedoc provides strong automation and an architecture that can connect EDC data to external AI or analytical models, but its current native EDC functionality is more clearly documented around automation than vendor-provided AI.
• OpenClinica: Its newer AI-assisted study-build offering applies AI to protocol-to-EDC setup, including CRFs and edit checks, but the documented AI footprint is currently concentrated on study build rather than ongoing clinical data management. 
• ClinCapture: ClinCapture has introduced AI-assisted study-build and natural-language rule-generation capabilities, although availability and maturity vary across its current AI offerings.

These platforms are worth monitoring as AI becomes more deeply integrated into clinical data systems. Their exclusion from the main seven does not imply weaker EDC performance overall; it reflects the narrower focus of this comparison on clearly documented AI use cases available within clinical data workflows today.

The seven platforms compared here apply AI to different parts of the EDC workflow, from study build and coding to source-data capture, clinical data review, and reporting.

For sponsors and CROs, the priority is to verify what the AI actually does, whether it is available in production, how its outputs are reviewed, and how it performs on representative study data. AI should reduce manual work in a defined workflow while keeping clinical and data-management teams in control.

Clinical trials: Are data managers ready for AI in EDC? 
AI-Powered Data Management products in Electronic Data Capture (EDC) Software | G2 
Electronic Data Capture Systems Market Size, Share, Growth & Industry Trends Analysis 2031